# A Study to Evaluate the Clinical Performance of VeriSee GLC for Screening of Glaucoma Suspect Using Color Fundus Images

> **NCT07550712** · — · COMPLETED · sponsor: **Acer Medical Inc.** · enrollment: 773 (actual)

## Conditions studied

- Glaucoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07550712
- **Lead sponsor:** Acer Medical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-26
- **Primary completion:** 2024-08-26
- **Final completion:** 2024-12-27
- **Target enrollment:** 773 (ACTUAL)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07550712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07550712, "A Study to Evaluate the Clinical Performance of VeriSee GLC for Screening of Glaucoma Suspect Using Color Fundus Images". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07550712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*